Skip to main content
. 2021 Oct 7;5(Suppl 2):e12589. doi: 10.1002/rth2.12589
Lab Evaluation

All Patients

n = 18,160

White Patients

n = 7,160

Black Patients

N = 6,238

P‐value
CBC or Hemoglobin 11,902 (65.5) 4,995 (69.8) 3,669 (58.8) < .001
Any Iron Evaluation 1,251 (6.9) 568 (7.9) 373 (6.0) < .001
Prothrombin Time/Partial Thromboplastin Time 4,597 (25.3) 2,061 (28.8) 1,238 (19.8) < .001
Fibrinogen 774 (4.3) 325 (4.5) 228 (3.7) 0.010
Von Willebrand Antigen 1,584 (8.7) 765 (10.7) 404 (6.5) < .001
Von Willebrand Ristocetin Cofactor Activity 1,553 (8.6) 692 (9.7) 429 (6.9) < .001
Factor VIII (Assay or Antigen) 1,700 (9.4) 821 (11.5) 438 (7.0) < .001
Platelet Aggregation 240 (1.3) 110 (1.5) 63 (1.0) 0.007
Other Factor Assays (II, V, VII, IX, X, XI, XII, XIII) 47 (0.3) 18 (0.3) 13 (0.2) 0.610